Eugene Kim

Eugene Kim

Auto-generated profile, based on publicly available information

Eugene Kim

Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience King’s College, London, United Kingdom

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JGJoanes Grandjean
Joanes Grandjean
GDGabriel Desrosiers-Gregoire
Gabriel Desrosiers-Gregoire
CACynthia Anckaerts
Cynthia Anckaerts
DADiego Angeles-Valdez
Diego Angeles-Valdez
FAFadi Ayad
Fadi Ayad
AHAndreas Hess
Andreas Hess

14 December 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
GNGabriel Nketiah
Gabriel Nketiah
MEMattijs Elschot
Mattijs Elschot
EKEugene Kim
Eugene Kim
JTJose R. Teruel
Jose R. Teruel
TSTom W. Scheenen
Tom W. Scheenen
KSKirsten M. Selnæs
Kirsten M. Selnæs

28 October 2019 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
MWMatthew A. White
Matthew A. White
ZLZiqiang Lin
Ziqiang Lin
EKEugene Kim
Eugene Kim
CHChristopher M. Henstridge
Christopher M. Henstridge
EAEmiliano Pena Altamira
Emiliano Pena Altamira
JSJemeen Sreedharan
Jemeen Sreedharan
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative condition that primarily affects the motor system and shares many features with frontotemporal dementia (FTD). Evidence suggests that ALS is a ‘dying-back’ disease, with peripheral denervation and axonal degeneration occurring before loss of motor neuron cell bodies. Distal to a nerve injury, a similar pattern of axonal degeneration can be seen, which is mediated by an active axon destruction mechanism called Wallerian degeneration. Sterile alpha and TIR motif-containing 1 (Sarm1) is a key gene in the Wallerian pathway and its deletion provides long-term protection against both Wallerian degeneration and Wallerian-like, non-injury induced axonopathy, a retrograde degenerative process that occurs in many neurodegenerative diseases where axonal transport is impaired. Here, we explored whether Sarm1 signalling could be a therapeutic target for ALS by deletingSarm1from a mouse model of ALS-FTD, a TDP-43Q331K, YFP-H double transgenic mouse.Sarm1deletion attenuated motor axon degeneration and neuromuscular junction denervation. Motor neuron cell bodies were also significantly protected. Deletion ofSarm1also attenuated loss of layer V pyramidal neuronal dendritic spines in the primary motor cortex. Structural MRI identified the entorhinal cortex as the most significantly atrophic region, and histological studies confirmed a greater loss of neurons in the entorhinal cortex than in the motor cortex, suggesting a prominent FTD-like pattern of neurodegeneration in this transgenic mouse model. Despite the reduction in neuronal degeneration,Sarm1deletion did not attenuate age-related behavioural deficits caused by TDP-43Q331K. However,Sarm1deletion was associated with a significant increase in the viability of male TDP-43Q331Kmice, suggesting a detrimental role of Wallerian-like pathways in the earliest stages of TDP-43Q331K-mediated neurodegeneration. Collectively, these results indicate that anti-SARM1 strategies have therapeutic potential in ALS-FTD.

1 January 2014 in Microvascular Research
Verified
Journal Article
Closed access
SSSpyros K. Stamatelos
Spyros K. Stamatelos
EKEugene Kim
Eugene Kim
APArvind P. Pathak
Arvind P. Pathak
Aleksander PopelAleksander Popel
Aleksander Popel

8 May 2012 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
EKEugene Kim
Eugene Kim
SSSpyros Stamatelos
Spyros Stamatelos
JCJana Cebulla
Jana Cebulla
ZBZaver M. Bhujwalla
Zaver M. Bhujwalla
Aleksander PopelAleksander Popel
Aleksander Popel
APArvind P. Pathak
Arvind P. Pathak

27 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APArvind P. Pathak
Arvind P. Pathak
EKEugene Kim
Eugene Kim
JZJiangyang Zhang
Jiangyang Zhang
MJMelina V. Jones
Melina V. Jones
Knowledge of the three-dimensional (3D) architecture of blood vessels in the brain is crucial because the progression of various neuropathologies ranging from Alzheimer's disease to brain tumors involves anomalous blood vessels. The challenges in obtaining such data from patients, in conjunction with development of mouse models of neuropathology, have made the murine brain indispensable for investigating disease induced neurovascular changes. Here we describe a novel method for “whole brain” 3D mapping of murine neurovasculature using magnetic resonance microscopy (μMRI). This approach preserves the vascular and white matter tract architecture, and can be combined with complementary MRI contrast mechanisms such as diffusion tensor imaging (DTI) to examine the interplay between the vasculature and white matter reorganization that often characterizes neuropathologies. Following validation with micro computed tomography (μCT) and optical microscopy, we demonstrate the utility of this method by: (i) combined 3D imaging of angiogenesis and white matter reorganization in both, invasive and non-invasive brain tumor models; (ii) characterizing the morphological heterogeneity of the vascular phenotype in the murine brain; and (iii) conducting “multi-scale” imaging of brain tumor angiogenesis, wherein we directly compared in vivo MRI blood volume measurements with ex vivo vasculature data.